MBX Biosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBX and other ETFs, options, and stocks.

About MBX

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio.

CEO

Peter Kent Hawryluk

CEOPeter Kent Hawryluk

Employees

Employees43

Headquarters

Carmel, Indiana

HeadquartersCarmel, Indiana

Founded

2018

Founded2018

Employees

Employees43

MBX Key Statistics

Market cap

460.59M

Market cap460.59M

Price-Earnings ratio

-6.25

Price-Earnings ratio-6.25

Dividend yield

—

Dividend yield—

Average volume

616.46K

Average volume616.46K

High today

$13.89

High today$13.89

Low today

$12.55

Low today$12.55

Open price

$13.00

Open price$13.00

Volume

513.07K

Volume513.07K

52 Week high

$27.50

52 Week high$27.50

52 Week low

$4.81

52 Week low$4.81

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own MBX. This list is generated using Robinhood data, and it’s not a recommendation.

MBX Biosciences

Why Robinhood?

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. Show more

MBX Key Statistics

Analyst ratings

100%

People also own

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio.